G. Vader and S. Lens, The Aurora kinase family in cell division and cancer, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol.1786, issue.1, pp.60-72, 2008.
DOI : 10.1016/j.bbcan.2008.07.003

S. Ruchaud, M. Carmena, and W. Earnshaw, Chromosomal passengers: conducting cell division, Nature Reviews Molecular Cell Biology, vol.117, issue.10, pp.798-812, 2007.
DOI : 10.1038/nrm2257

T. Sardon, I. Peset, B. Petrova, and I. Vernos, Dissecting the role of Aurora A during spindle assembly, The EMBO Journal, vol.61, issue.19, pp.2567-79, 2008.
DOI : 10.1091/mbc.E08-02-0198

A. Seki, J. Coppinger, C. Jang, J. Yates, and G. Fang, Bora and the Kinase Aurora A Cooperatively Activate the Kinase Plk1 and Control Mitotic Entry, Science, vol.320, issue.5883, pp.1655-1663, 2008.
DOI : 10.1126/science.1157425

S. Lens and R. Medema, The Survivin/Aurora B Complex: Its Role in Coordinating Tension and Attachment, Cell Cycle, vol.2, issue.6, pp.507-517, 2003.
DOI : 10.4161/cc.2.6.559

C. Ditchfield, V. Johnson, and A. Tighe, Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores, The Journal of Cell Biology, vol.114, issue.2, pp.267-80, 2003.
DOI : 10.1038/2496

C. Ditchfield, N. Keen, and S. Taylor, The Ipl1/Aurora Kinase Family: Methods of Inhibition and Functional Analysis in Mammalian Cells, Methods Mol Biol, vol.296, pp.371-81, 2005.
DOI : 10.1385/1-59259-857-9:371

S. Sen, H. Zhou, and R. White, A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines, Oncogene, vol.14, issue.18, pp.2195-200, 1997.
DOI : 10.1038/sj.onc.1201065

J. Bischoff, L. Anderson, and Y. Zhu, A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers, The EMBO Journal, vol.17, issue.11, pp.3052-65, 1998.
DOI : 10.1093/emboj/17.11.3052

R. Giet, C. Petretti, and C. Prigent, Aurora kinases, aneuploidy and cancer, a coincidence or a real link?, Trends in Cell Biology, vol.15, issue.5, pp.241-50, 2005.
DOI : 10.1016/j.tcb.2005.03.004
URL : https://hal.archives-ouvertes.fr/inserm-00966568

N. Keen and S. Taylor, Aurora-kinase inhibitors as anticancer agents, Nature Reviews Cancer, vol.64, issue.12, pp.927-963, 2004.
DOI : 10.1038/sj.onc.1207593

F. Girdler, K. Gascoigne, and P. Eyers, Validating Aurora B as an anti-cancer drug target, Journal of Cell Science, vol.119, issue.17, pp.3664-75, 2006.
DOI : 10.1242/jcs.03145

J. Jackson, D. Patrick, M. Dar, and P. Huang, Targeted anti-mitotic therapies: can we improve on tubulin agents?, Nature Reviews Cancer, vol.112, issue.2, pp.107-124, 2007.
DOI : 10.1038/nrc2049

S. Hauf, R. Cole, and S. Laterra, The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore???microtubule attachment and in maintaining the spindle assembly checkpoint, The Journal of Cell Biology, vol.114, issue.21, pp.281-94, 2003.
DOI : 10.1073/pnas.96.20.11335

B. Gadea and J. Ruderman, Aurora Kinase Inhibitor ZM447439 Blocks Chromosome-induced Spindle Assembly, the Completion of Chromosome Condensation, and the Establishment of the Spindle Integrity Checkpoint in Xenopus Egg Extracts, Molecular Biology of the Cell, vol.16, issue.3, pp.1305-1323, 2005.
DOI : 10.1091/mbc.E04-10-0891

E. Harrington, D. Bebbington, and J. Moore, VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo, Nature Medicine, vol.10, issue.3, pp.262-269, 2004.
DOI : 10.1038/nm1003

D. Fancelli, J. Moll, and M. Varasi, ]pyrazoles:?? Identification of a Potent Aurora Kinase Inhibitor with a Favorable Antitumor Kinase Inhibition Profile, Journal of Medicinal Chemistry, vol.49, issue.24, pp.7247-51, 2006.
DOI : 10.1021/jm060897w

C. Soncini, P. Carpinelli, and L. Gianellini, PHA-680632, a Novel Aurora Kinase Inhibitor with Potent Antitumoral Activity, Clinical Cancer Research, vol.12, issue.13, pp.4080-4089, 2006.
DOI : 10.1158/1078-0432.CCR-05-1964

K. Hoar, A. Chakravarty, and C. Rabino, MLN8054, a Small-Molecule Inhibitor of Aurora A, Causes Spindle Pole and Chromosome Congression Defects Leading to Aneuploidy, Molecular and Cellular Biology, vol.27, issue.12, pp.4513-4538, 2007.
DOI : 10.1128/MCB.02364-06

O. Gautschi, J. Heighway, P. Mack, P. Purnell, P. Lara et al., Aurora Kinases as Anticancer Drug Targets, Clinical Cancer Research, vol.14, issue.6, pp.1639-1687, 2008.
DOI : 10.1158/1078-0432.CCR-07-2179

J. Bain, L. Plater, and M. Elliott, The selectivity of protein kinase inhibitors: a further update, Biochemical Journal, vol.408, issue.3, pp.297-315, 2007.
DOI : 10.1042/BJ20070797
URL : https://hal.archives-ouvertes.fr/hal-00478827

G. Noronha, J. Cao, and C. Chow, Inhibitors of ABL and the ABL-T315I Mutation, Current Topics in Medicinal Chemistry, vol.8, issue.10, pp.905-926, 2008.
DOI : 10.2174/156802608784911635

J. Zhang, T. Chung, and K. Oldenburg, A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays, Journal of Biomolecular Screening, vol.4, issue.2, pp.67-73, 1999.
DOI : 10.1177/108705719900400206

C. Nguyen, E. Bisagni, F. Lavelle, M. Bissery, and C. Huel, Synthesis and antitumor properties of new 4-methyl-substituted-pyrido[4,3-b]indoles (gamma-carbolines), Anticancer Drug Des, vol.7, pp.219-252, 1992.

M. Delacour-larose, . Ma, D. Skoufias, R. Margolis, and S. Dimitrov, Distinct Dynamics of Aurora B and Survivin During Mitosis, Cell Cycle, vol.3, issue.11, pp.1418-1444, 2004.
DOI : 10.4161/cc.3.11.1203

M. Delacour-larose, M. Thi, S. Dimitrov, and A. Molla, Role of Survivin Phosphorylation by Aurora B in Mitosis, Cell Cycle, vol.6, issue.15, pp.1878-85, 2007.
DOI : 10.4161/cc.6.15.4482
URL : https://hal.archives-ouvertes.fr/inserm-00336297

D. Duca, D. Werbowetski, T. , D. Maestro, and R. , Spheroid Preparation from Hanging Drops: Characterization of a Model of Brain Tumor Invasion, Journal of Neuro-Oncology, vol.67, issue.3, pp.295-303, 2004.
DOI : 10.1023/B:NEON.0000024220.07063.70

C. Badouel, R. Körner, M. Frank-vaillant, A. Couturier, E. Nigg et al., M-phase MELK activity is regulated by MPF and MAPK, Cell Cycle, vol.5, issue.8, pp.883-892, 2006.
DOI : 10.4161/cc.5.8.2683

G. Cheetham, P. Charlton, J. Golec, and J. Pollard, Structural basis for potent inhibition of the Aurora kinases and a T315I multi-drug resistant mutant form of Abl kinase by VX-680, Cancer Letters, vol.251, issue.2, pp.323-332, 2007.
DOI : 10.1016/j.canlet.2006.12.004

G. Cheetham, R. Knegtel, and J. Coll, Crystal Structure of Aurora-2, an Oncogenic Serine/Threonine Kinase, Journal of Biological Chemistry, vol.277, issue.45, pp.42419-42441, 2002.
DOI : 10.1074/jbc.C200426200

R. Bayliss, T. Sardon, I. Vernos, and E. Conti, Structural Basis of Aurora-A Activation by TPX2 at the Mitotic Spindle, Molecular Cell, vol.12, issue.4, pp.851-62, 2003.
DOI : 10.1016/S1097-2765(03)00392-7

F. Sessa, M. Mapelli, and C. Ciferri, Mechanism of Aurora B Activation by INCENP and Inhibition by Hesperadin, Molecular Cell, vol.18, issue.3, pp.379-91, 2005.
DOI : 10.1016/j.molcel.2005.03.031

M. Alvarez, E. Roman, E. Santos, and L. Raez, New targets for non-small-cell lung cancer therapy, Expert Review of Anticancer Therapy, vol.7, issue.10, pp.1423-1460, 2007.
DOI : 10.1586/14737140.7.10.1423